News

The CDC expands eligibility and strengthens recommendations for COVID-19 boosters

CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2

Findings suggest that psychological risk factors may increase hospitalization risk

Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing

Corporate dollars elevate commercial interests over health expertise

The FDA expanded the eligibility for the vaccine booster dose to individuals five through 11 years of age

Ethical guidelines in clinical research can reduce risk, increase participation, protect the welfare of participants

Researchers find patterns in electronic health record data to better identify those likely to have the condition

More than $70 billion in costs saved over one year following vaccine roll-out

The antibody, already in clinical trials to treat COVID-19, may be effective against future variants

Blood adenosine levels at day 15 post birth could be a major predictor of brain injury occurrence

To address problems with how autoimmune disease is studied by the NIH a new, funded office is needed

Technique can aid in seizure diagnosis and surgical planning

New study is an important milestone in developing genetic risk scores

Private companies and universities among those that may be failing to protect patient confidentiality

NIH findings could lead to ways to combat future SARS-CoV-2 variants

Neural network learns to differentiate between healthy and inflamed bones using finger joints

Study examines death rates for cardiovascular diseases in various Asian ethnicity subgroups

Asian, Hispanic, and Black Americans are at increased risk for diabetes at lower weights, younger ages